Cytokinetics (CYTK) PT Raised to $65 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $74.13 +0.93%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald analyst Charles Duncan raised the price target on Cytokinetics (NASDAQ: CYTK) to $65.00 (from $59.00) while maintaining a Overweight rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
- Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
